Lurasidone

Lurasidone
Product Description

Atypical antipsychotic with a low metabolic side-effect burden, approved for schizophrenia and bipolar depression; combines dopamine D2 and serotonin 5-HT2A/5-HT7 receptor antagonism. Its comparatively minimal effect on weight, lipids and glucose metabolism distinguishes it from several older atypical antipsychotics, making it a useful option for patients at higher metabolic risk. Because absorption is significantly increased when taken with food, it is generally dosed once daily with a meal. Its dual approval in both schizophrenia and bipolar depression allows it to serve overlapping patient populations within a single molecule. 

Read more Show less

Bioscience Group

  • Country/Region:
    United Kingdom
  • Founded:
    2012
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    500 - 999
Company types
Licensee
Manufacturer/Innovator
Pharmaceutical company
View company profile
Categories
more categories Show less
Specifications
  • Details
    Modified-release tablets 37 mg or 74 mg 

  • Selling Points
    Key advantages:

    Low weight-gain and metabolic risk versus other atypicals 

    Approved for both schizophrenia and bipolar depression 

    Once-daily dosing with food for consistent absorption 

More specifications Fewer specifications

Bioscience Group

  • Country/Region:
    United Kingdom
  • Founded:
    2012
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    500 - 999
Company types
Licensee
Manufacturer/Innovator
Pharmaceutical company
View company profile

More Products from Bioscience Group (9)

  • Diclofenac + Omeprazole

    Product Diclofenac + Omeprazole

    Dual-release capsules Diclofenac – 75 mg; Omeprazole – 20 mg Combines an NSAID (diclofenac) for pain and inflammation relief with a proton-pump inhibitor (omeprazole) that protects the gastric mucosa, reducing the risk of NSAID-induced ulcers. Diclofenac inhibits cyclo-oxygenase (COX-1/COX-2), lowering pr...
  • Almotriptan

    Product Almotriptan

    Selective 5-HT1B/1D receptor agonist (triptan) that constricts dilated cranial vessels and inhibits neurogenic inflammation, relieving acute migraine attacks with or without aura. Almotriptan also blocks the release of vasoactive neuropeptides from trigeminal nerve endings, addressing a key part of migrain...
  • Bupropion

    Product Bupropion

    An aminoketone antidepressant acting as a norepinephrine– dopamine reuptake inhibitor (NDRI), a mechanism distinct from SSRIs and SNRIs. Relieves symptoms of major depressive disorder with a low incidence of sexual dysfunction and sedation compared with SSRIs. Its mildly activating profile can also benefit...
  • Duloxetine

    Product Duloxetine

    Serotonin–norepinephrine reuptake inhibitor that acts both centrally and on the descending pain-modulating pathways of the spinal cord. This dual action underlies its use in diabetic peripheral neuropathic pain and fibromyalgia alongside depression and generalized anxiety disorder. Because the analgesic ef...
  • Opipramol

    Product Opipramol

    Atypical anxiolytic/antidepressant acting primarily via σ1/σ2-receptor agonism rather than monoamine reuptake inhibition, a mechanism that differentiates it from SSRIs and benzodiazepines. Effective for generalized anxiety disorder and somatoform disorders, with low dependence potential. Its additional ant...
  • Paliperidone

    Product Paliperidone

    Atypical antipsychotic and the active metabolite of risperidone, combining dopamine D2 and serotonin 5-HT2A antagonism; used for schizophrenia and schizoaffective disorder with predictable, osmotically controlled release. Because it is already the active metabolite, paliperidone bypasses the hepatic CYP2D6...
  • Phenibut

    Product Phenibut

    GABA-B receptor agonist with anxiolytic, nootropic and mild sedative properties; reduces psycho-emotional tension and improves sleep and cognitive performance under stress. Structurally related to GABA with a phenyl-ring modification that allows it to cross the blood-brain barrier, phenibut combines calmin...
  • Quetiapine XR

    Product Quetiapine XR

    Atypical antipsychotic acting on dopamine D2 and serotonin 5-HT2A receptors, with additional activity at histamine H1 and adrenergic α1 receptors that contributes to its sedative and anxiolytic effects. Effective in schizophrenia and bipolar disorder, with once-daily dosing due to prolonged-release technol...
  • Vortioxetine

    Product Vortioxetine

    Multimodal antidepressant combining serotonin reuptake inhibition with direct modulation of multiple serotonin receptors, including 5-HT3, 5-HT7 and 5-HT1A; associated with pro-cognitive benefits in addition to mood improvement in major depressive disorder. This receptor-modulating activity is thought to u...